ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 102 filers reported holding ANACOR PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,787,000 | -48.9% | 33,431 | +8.1% | 0.00% | -50.0% |
| Q4 2015 | $3,495,000 | +40.6% | 30,933 | +46.5% | 0.01% | +20.0% |
| Q3 2015 | $2,485,000 | +65.8% | 21,112 | +9.1% | 0.01% | +66.7% |
| Q2 2015 | $1,499,000 | -26.7% | 19,355 | -45.2% | 0.00% | -40.0% |
| Q1 2015 | $2,044,000 | +58.3% | 35,330 | -11.7% | 0.01% | +66.7% |
| Q4 2014 | $1,291,000 | +13.1% | 40,030 | -14.2% | 0.00% | 0.0% |
| Q3 2014 | $1,141,000 | -4.1% | 46,630 | -30.5% | 0.00% | 0.0% |
| Q2 2014 | $1,190,000 | -3.5% | 67,130 | +8.9% | 0.00% | -25.0% |
| Q1 2014 | $1,233,000 | +49.6% | 61,630 | +25.4% | 0.00% | +100.0% |
| Q4 2013 | $824,000 | – | 49,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |